Robotic-assisted Resection of a Diaphragmatic Metastasis of a Gastrointestinal Stromal Tumor
- PMID: 34534200
- DOI: 10.1097/SLE.0000000000000993
Robotic-assisted Resection of a Diaphragmatic Metastasis of a Gastrointestinal Stromal Tumor
Abstract
Gastrointestinal stromal tumors (GISTs) are relatively rare mesenchymal tumors. The treatment of these tumors has drastically changed based on molecular treatment methods, namely tyrosine kinase inhibitors, which have led to impressive survival benefits. While medical management has enhanced patient outcomes, surgery is still the standard of care for stable, completely resectable primary tumors or metastases that are >2 cm. This case presents the resection of a diaphragmatic metastasis of a tyrosine kinase inhibitor-controlled GIST in a 51-year-old male. The surgery was collaboratively approached from both the thoracic and abdominal cavities, utilizing the da Vinci robotic system. Prior data is limited regarding patient outcomes after robotic-assisted resection of GISTs. However, small case series have shown it to be a safe and effective surgical option. Our patient's quick recovery and return to normal function demonstrate the successful use of robotic-assisted surgery for GIST resection.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
R.M.H. is a speaker and proctor for Intuitive Surgical; also a speaker for WL Gore. The remaining authors declare no conflicts of interest.
References
-
- Poveda A, García Del Muro X, López-Guerrero JA, et al. GEIS guidelines for gastrointestinal sarcomas (GIST). Cancer Treat Rev. 2017;55:107–119.
-
- Rubin BP, Fletcher JA, Fletcher CD. Molecular insights into the histogenesis and pathogenesis of gastrointestinal stromal tumors. Int J Surg Pathol. 2000;8:5–10.
-
- Plaat BE, Hollema H, Molenaar WM, et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol. 2000;18:3211–3220.
-
- Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004;364:1127–1134.
-
- Demetri GD, Benjamin R, Blanke CD, et al. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)—expansion and update of NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2004;2:1–26.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
